Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics

por Vervaeke, P., Borgos, S.E., Sanders, N.N., Combes, F.
Publicado 2022

Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation

por Halamoda-Kenzaoui, B., Vandebriel, R.J., Howarth, A., Siccardi, M., David, C.A.W., Liptrott, N.J., Santin, M., Borgos, S.E., Bremer-Hoffmann, S., Caputo, F.
Publicado 2021

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities

por Hammond, Suzan M, Aartsma‐Rus, Annemieke, Alves, Sandra, Borgos, Sven E, Buijsen, Ronald A M, Collin, Rob W J, Covello, Giuseppina, Denti, Michela A, Desviat, Lourdes R, Echevarría, Lucía, Foged, Camilla, Gaina, Gisela, Garanto, Alejandro, Goyenvalle, Aurelie T, Guzowska, Magdalena, Holodnuka, Irina, Jones, David R, Krause, Sabine, Lehto, Taavi, Montolio, Marisol, Van Roon‐Mom, Willeke, Arechavala‐Gomeza, Virginia
Publicado 2021